GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 77 institutions reported holding it in 13F filings for Q3 2026, worth $25.9M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 20, 2026
- $104.3M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $155.7K in total
- 6
- 13F holdersQ3 2026, +7 vs. previous quarter
- 77
- 13F valueReported value at the end of Q3 2026
- $25.9M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $8.00K
- 0.0% year over year
- Net income, FY2025
- -$32.1M
- No comparable prior period
- Free cash flow, FY2025
- -$26.4M
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $32.1M (401812.5% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 4.53M
- Shares sold short
- Change
- −113.4K
- −2.4% vs. previous
- Days to cover
- 8.32
- At average daily volume
Superinvestors holding GNLX, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding GNLX at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by GENELUX Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 (view filing)5:20 PM ET | Nov 3 | 2 days | Cappello JosephChief Technical Officer | SSale | −668 | $2.04 | −$1.36K | −0.2%317.8K after | |
| Nov 5, 2026 (view filing)5:20 PM ET | Nov 3 | 2 days | Zindrick ThomasPresident and CEO | SSale | −3.09K | $2.05 | −$6.32K | −0.3%1.22M after | |
| Nov 5, 2026 (view filing)5:20 PM ET | Nov 3 | 2 days | Yu TonyChief Scientific Officer | SSale | −668 | $2.01 | −$1.34K | −0.3%258.0K after | |
| Sep 2, 2026 (view filing)7:05 PM ET | Aug 31 | 2 days | Cappello JosephChief Technical Officer | SSale | −10.3K | $2.74 | −$28.1K | −3.1%318.5K after | |
| Sep 2, 2026 (view filing)7:05 PM ET | Aug 31 | 2 days | Zindrick ThomasPresident and CEO | SSale | −34.5K | $2.67 | −$91.9K | −2.7%1.23M after | |
| Sep 2, 2026 (view filing)7:05 PM ET | Aug 31 | 2 days | Yu TonyChief Scientific Officer | SSale | −9.68K | $2.75 | −$26.7K | −3.6%258.7K after | |
| Aug 4, 2026 (view filing)8:20 PM ET | Aug 4 | Same day | Yu TonyChief Scientific Officer | SSale | −653 | $2.94 | −$1.92K | −0.2%268.4K after | |
| Aug 4, 2026 (view filing)8:20 PM ET | Aug 4 | Same day | Cappello JosephChief Technical Officer | SSale | −653 | $2.95 | −$1.92K | −0.2%328.7K after | |
| Aug 4, 2026 (view filing)8:20 PM ET | Aug 4 | Same day | Zindrick ThomasPresident and CEO | SSale | −3.02K | $2.95 | −$8.91K | −0.2%1.26M after | |
| Jul 2, 2026 (view filing)4:35 PM ET | Jul 1 | 1 day | Smither John WDirector | SSale | −12.0K | $2.91 | −$34.9K | −11.6%91.4K after |
Top 10 13F holders, Q3 2026
See all 77 holdersThe largest institutional positions in GENELUX Corp at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodward Diversified Capital, LLC | 2,378,755 | $6.02M | 2.36% | +116,647+5.2% | Added |
| Vanguard Capital Management LLC | 1,660,995 | $4.20M | 0.00% | −16,729−1.0% | Reduced |
| Bleichroeder LP | 1,380,666 | $3.49M | 0.34% | 00.0% | Unchanged |
| BlackRock, Inc. | 433,267 | $1.10M | 0.00% | −6,335−1.4% | Reduced |
| Geode Capital Management, LLC | 428,593 | $1.08M | 0.00% | −10,620−2.4% | Reduced |
| CM Management, LLC | 400,000 | $1.01M | 0.68% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 300,081 | $759.2K | 0.00% | +300,081 | New |
| Vanguard Fiduciary Trust Co | 256,029 | $647.8K | 0.00% | +19,685+8.3% | Added |
| Global Retirement Partners, LLC | 227,854 | $576.5K | 0.01% | 00.0% | Unchanged |
| LPL Financial LLC | 157,157 | $397.6K | 0.00% | −700−0.4% | Reduced |
Holders of 5% or more of GNLX
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of GENELUX Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G | 9.99%4.22M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Szalay Aladar | 13G/A | 6.20%2.83M shares | −2.00 ppfrom 8.20% | Feb 2, 20245 filings | Nov 4, 2026 | SEC |